Public sector seeks to bridge 'valley of death'

Moran, Nuala
March 2007
Nature Biotechnology;Mar2007, Vol. 25 Issue 3, p266
Academic Journal
The article reports on the increase of funds for biotechnology research in the United States, Australia and Great Britain. The financiers have realized the benefits of decreasing the burden of pharmaceutical companies in their drug development projects. The funds would ensure that the gap of academic grants and that of the industry is lessened.


Related Articles

  • Grants roundup.  // Medical Device Daily;2/17/2010, Vol. 14 Issue 31, p4 

    The article announces a grant received by San Diego State University, Biocom, the San Diego Workforce Partnership and the Southern California Biotechnology Center at Miramar College from the U.S. Department of Labor to fund the Biotechnology Readiness, Immersion, Certification and Degrees for...

  • CIRM Grant Total Tops $614M; More Industry Opps Coming. Morrison, Trista // BioWorld Today;8/15/2008, Vol. 19 Issue 159, p1 

    The article reports the awarding of $614.3 million grants by the California Institute for Regenerative Medicine which will be used mainly for basic research and non-profit training programs and majority of the grant will be for the biotech industry.

  • Vasomedical gets funding.  // Long Island Business News (7/1993 to 5/2009);09/29/2000, Vol. 47 Issue 39, p21A 

    Focuses on biotechnology firm Vasomedical's receipt of money from New York State's Empire State Development agency. Proposal to purchase and renovate a facility; Part of efforts to consolidate its manufacturing operations.

  • VC Investments Drop By 61 Percent in 1st Quarter. Webb, Marion // San Diego Business Journal;5/2/2005, Vol. 26 Issue 18, p11 

    Reports on the local venture capital (VC) investments in San Diego, California. Drop in biotechnology investments; Shift in VC investment from starting companies to later-stage companies; Increase in the funding gap for early-stage developments; Effect of the rising competition among VC groups...

  • ImmuneWorks, LLC.  // Indianapolis Business Journal;3/17/2008 BioFutures Supplement, Vol. 29, p60 

    The article reports on the $1.5 million grant awarded to Indiana biotechnology company ImmuneWorks LLC. According to the company, it will use the grant to complete preclinical development of its lead compound in the treatment of idiopathic pulmonary fibrosis and to submit the company's...

  • ParaPRO, LLC.  // Indianapolis Business Journal;3/17/2008 BioFutures Supplement, Vol. 29, p61 

    The article reports on the $2.1 million grant received by Indiana-based biotechnology company ParaPRO LLC. According to the firm, the funds will be used to help finance the phase 3 trials for its lead investigational product, a cream rinse containing Spinosad for the treatment of human head...

  • Tracera, LLC.  // Indianapolis Business Journal;3/17/2008 BioFutures Supplement, Vol. 29, p63 

    The article reports on the $583,000 matching funds grant awarded to Indiana-based biotechnology company Tracera LLC. According to Tracera, it will use the funds to complete its automated radiochemistry module, the TS-1. The grant, the company adds, supports Tracera's efforts to become a...

  • State's $4.7M grant to have big effect on Garfield Heights drug-testing biz. Glenn, Brandon // Crain's Cleveland Business;6/5/2006, Vol. 27 Issue 23, p6 

    The article informs that biotechnology company ChanTest Inc. of Garfield Heights, Ohio, looks poised for its biggest breakthrough, due to a $4.7 million grant from the state of Ohio. The grant will fund a project in which ChanTest will create a library of 72 cellular proteins that occur in...

  • The Grant Story. Grims, Randy // BioPharm International;Aug2003, Vol. 16 Issue 8, p58 

    Focuses on the advantage of grant funding opportunities received by the biotechnology companies in the U.S. Reduction of investment dilution; Impact of economic downturn on venture capital market; Accounts on the winning strategies for grant funding.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics